Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 May;15(5):684–695. doi: 10.1128/aac.15.5.684

Phosphonopeptides as Antibacterial Agents: Alaphosphin and Related Phosphonopeptides

John G Allen 1, Frank R Atherton 1, Michael J Hall 1, Cedric H Hassall 1, Simon W Holmes 1, Robert W Lambert 1, Louis J Nisbet 1,†, Peter S Ringrose 1
PMCID: PMC352739  PMID: 43113

Abstract

Alaphosphin, l-alanyl-l-1-aminoethylphosphonic acid, was selected from a range of phosphonopeptides for evaluation in humans on the basis of its antibacterial activity, pharmacokinetics, and stability to intestinal and kidney peptidases. In vitro, the antibacterial action was antagonized by small peptides, resulting in low activity on peptone media. On an antagonist-free medium alaphosphin was bactericidal and rapidly lysed most susceptible gram-negative bacteria, but it was largely bacteriostatic and essentially nonlytic against gram-positive organisms. Its spectrum included most strains normally isolated from urinary tract infections, but potency was greatly reduced by very high inoculum levels and by alkaline pH. Although strains of Proteus and Pseudomonas were less susceptible to alaphosphin than were other common gram-negative bacteria, like other species they formed spheroplasts when exposed under appropriate conditions. Alaphosphin was equally effective against penicillin-susceptible and -resistant strains and showed no cross-resistance with known antibiotics. Good synergy and increased bactericidal activity were demonstrated with combinations of alaphosphin and d-cycloserine or β-lactam antibiotics.

Full text

PDF
684

Images in this article

691Image
on p.691

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. G., Atherton F. R., Hall M. J., Hassall C. H., Holmes S. W., Lambert R. W., Nisbet L. J., Ringrose P. S. Phosphonopeptides, a new class of synthetic antibacterial agents. Nature. 1978 Mar 2;272(5648):56–58. doi: 10.1038/272056a0. [DOI] [PubMed] [Google Scholar]
  2. Atherton F. R., Hall M. J., Hassall C. H., Lambert R. W., Ringrose P. S. Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships. Antimicrob Agents Chemother. 1979 May;15(5):677–683. doi: 10.1128/aac.15.5.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Donlon J., Fottrell P. F. Purification and characterization of one of the forms of peptide hydrolases from guinea-pig small intestinal mucosa. Biochim Biophys Acta. 1973 Dec 19;327(2):425–436. doi: 10.1016/0005-2744(73)90426-9. [DOI] [PubMed] [Google Scholar]
  4. ELION G. B., SINGER S., HITCHINGS G. H. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem. 1954 Jun;208(2):477–488. [PubMed] [Google Scholar]
  5. Farrell W., Wilks M., Drasar F. A. The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin. J Antimicrob Chemother. 1977 Sep;3(5):459–462. doi: 10.1093/jac/3.5.459. [DOI] [PubMed] [Google Scholar]
  6. Fu K. P., Neu H. C. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978 Mar;13(3):358–367. doi: 10.1128/aac.13.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greenwood D., O'Grady F. FL 1060: a new beta-lactam antibiotic with novel properties. J Clin Pathol. 1973 Jan;26(1):1–6. doi: 10.1136/jcp.26.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greenwood D., O'Grady F. The two sites of penicillin action in Escherichia coli. J Infect Dis. 1973 Dec;128(6):791–794. doi: 10.1093/infdis/128.6.791. [DOI] [PubMed] [Google Scholar]
  9. Grey D., Hamilton-Miller J. M. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole. J Med Microbiol. 1977 Aug;10(3):273–279. doi: 10.1099/00222615-10-3-273. [DOI] [PubMed] [Google Scholar]
  10. Grunberg E., Cleeland R., Beskid G., DeLorenzo W. F. In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics. Antimicrob Agents Chemother. 1976 Apr;9(4):589–594. doi: 10.1128/aac.9.4.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HOEPRICH P. D. ALANINE: CYCLOSERINE ANTAGONISM. VI. DEMONSTRATION OF D-ALANINE IN THE SERUM OF GUINEA PIGS AND MICE. J Biol Chem. 1965 Apr;240:1654–1660. [PubMed] [Google Scholar]
  12. Melchior N. H., Blom J., Tybring L., Birch-Andersen A. Light and electron microscopy of the early response of Escherichia coli to a 6beta-amidinopenicillanic acid (FL 1060). Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Aug;81(4):393–407. doi: 10.1111/j.1699-0463.1973.tb02222.x. [DOI] [PubMed] [Google Scholar]
  13. O'Grady F., Mackintosh I. P., Greenwood D., Watson B. W. Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder. Br J Exp Pathol. 1973 Jun;54(3):283–290. [PMC free article] [PubMed] [Google Scholar]
  14. Stamey T. A., Bragonje J. Resistance to nalidixic acid. A misconception due to underdosage. JAMA. 1976 Oct 18;236(16):1857–1860. [PubMed] [Google Scholar]
  15. Tseng J. T., Bryan L. E., Van den Elzen H. M. Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1972 Sep;2(3):136–141. doi: 10.1128/aac.2.3.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tybring L. Special aspects of laboratory investigations with mecillinam. J Antimicrob Chemother. 1977 Jul;3 (Suppl B):23–27. doi: 10.1093/jac/3.suppl_b.23. [DOI] [PubMed] [Google Scholar]
  17. Verbist L. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978 Mar;13(3):349–357. doi: 10.1128/aac.13.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES